| |
| |
|
| Insider
Information: |
Shah Pratik |
| Relationship: |
Executive Chairperson,... |
| City: |
Minneapolis |
| State: |
MN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
25,000 |
|
|
Indirect Shares
|
2,629,925 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,654,925 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ocera Therapeutics Inc |
OCRX |
Director |
|
0 |
2013-07-15 |
2,500,002 |
Premium* |
|
|
Auspex Pharmaceuticals, Inc. |
ASPX |
President and CEO, Dir... |
2015-05-05 |
0 |
|
0 |
Premium* |
|
|
Synthorx, Inc. |
THOR |
Director |
2020-01-23 |
0 |
2020-01-23 |
0 |
Premium* |
|
|
Design Therapeutics, Inc. |
DSGN |
Executive Chairperson,... |
2021-03-30 |
25,000 |
2021-03-30 |
129,923 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
7 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DSGN |
Design Therapeutics, Inc. |
Executive Chairperson |
• • – |
2021-03-30 |
4 |
B |
$20.00 |
$500,000 |
D/D |
25,000 |
25,000 |
2.81 |
- |
|
| DSGN |
Design Therapeutics, Inc. |
Executive Chairperson |
• • – |
2021-03-30 |
4 |
A |
$0.00 |
$0 |
I/I |
104,923 |
129,923 |
0 |
- |
|
| THOR |
Synthorx, Inc. |
Director |
– • – |
2020-01-23 |
4 |
D |
$68.00 |
$4,244,016 |
D/D |
(62,412) |
0 |
0 |
- |
|
| ASPX |
Auspex Pharmaceuticals, I... |
President and CEO |
• • – |
2015-05-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(903,018) |
0 |
0 |
- |
|
| ASPX |
Auspex Pharmaceuticals, I... |
President and CEO |
• • – |
2014-02-10 |
4 |
B |
$12.00 |
$99,996 |
D/D |
8,333 |
903,018 |
2.81 |
- |
|
| ASPX |
Auspex Pharmaceuticals, I... |
President and CEOOfficer |
• • – |
2014-02-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
894,685 |
|
- |
|
| OCRX |
Ocera Therapeutics Inc |
Director |
– • – |
2013-07-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,500,002 |
|
- |
|
7 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
